CMS is adding value-based care (VBC) risk faster than many providers can build the data and tech capacity they need to succeed.
|Podcasts|March 15, 2017
Patient Activation and Empowerment: Mandi Bishop Interviews Raj Toleti
Raj Toleti, CEO and founder of HealthGrid, has created patient-driven technologies to help empower them when they are accessing care.
Advertisement
Raj Toleti, CEO and founder of HealthGrid, has created patient-driven technologies to help empower them when they are accessing care.
During the latest Managed Care Cast, Mandi Bishop, chief evangelist and founder of Aloha Health, and Toleti discuss how health technology solutions will help move the needle on value-based care transformations, patient activation, improving patient portals and information sharing, and more.
Listen below or through one of these podcast services:
iTunes:
TuneIn:
Stitcher:
Advertisement
Related to this article
Phase 3 wins for ianalumab and dazodalibep bring targeted therapies closer for Sjögren disease as patients face diagnostic delays and high costs.
Although PMOS Awareness Month has ended, the conversation continues, with experts saying closing diagnostic and care gaps requires ongoing efforts.
FDA accepted United Therapeutics' sNDA for inhaled treprostinil in IPF. Here's what it could mean for patient access, coverage, and costs
CAR T-cell therapy must be treated as a complete "vein-to-vein" episode, with community practices needing to take control of cases for a period of time.
As AI proliferates, patients, caregivers, and others outside the medical world are using its tools to deal with cancer, but not always in obvious ways.
Payers cover novel cancer drugs but not the staffing, training, and monitoring to deliver them, leaving practices to absorb costs.
The 2026 COA Payer Exchange and Innovation Summit began with a panel on AI and the ever-changing digital infrastructure in community oncology.
Advertisement
Advertisement
Trending on AJMC
1
Pharmacists Bridge the Vaccine Trust Gap as COVID-19 Persists
2
Pipeline Advances in Sjögren Disease Bring Targeted Therapies Closer
3
VYD2311 Shows Superior Safety vs mRNA COVID-19 Vaccine
4
Lung Cancer Screening Lags for People With HIV as Eligibility Triples
5